NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 168 filers reported holding NEKTAR THERAPEUTICS in Q3 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $169,862,000 | -9.9% | 13,843,692 | +26.2% | 0.03% | -20.5% |
| Q3 2016 | $188,481,000 | +29.6% | 10,970,974 | +7.3% | 0.04% | +21.9% |
| Q2 2016 | $145,452,000 | +5.5% | 10,221,478 | +1.9% | 0.03% | 0.0% |
| Q1 2016 | $137,905,000 | -17.0% | 10,029,475 | +1.7% | 0.03% | -15.8% |
| Q4 2015 | $166,103,000 | +54.8% | 9,857,716 | +0.7% | 0.04% | +35.7% |
| Q3 2015 | $107,276,000 | -7.7% | 9,787,913 | +5.4% | 0.03% | 0.0% |
| Q2 2015 | $116,205,000 | +117.0% | 9,288,975 | +90.8% | 0.03% | +115.4% |
| Q1 2015 | $53,562,000 | -27.0% | 4,869,231 | +2.9% | 0.01% | -27.8% |
| Q4 2014 | $73,367,000 | +41.2% | 4,733,348 | +9.9% | 0.02% | +20.0% |
| Q3 2014 | $51,975,000 | -9.5% | 4,306,099 | -3.9% | 0.02% | -6.2% |
| Q2 2014 | $57,442,000 | -2.6% | 4,480,672 | -7.9% | 0.02% | -5.9% |
| Q1 2014 | $58,947,000 | +19.9% | 4,863,573 | +12.3% | 0.02% | +13.3% |
| Q4 2013 | $49,165,000 | +7.5% | 4,331,732 | -1.1% | 0.02% | 0.0% |
| Q3 2013 | $45,752,000 | +4.4% | 4,380,285 | +15.4% | 0.02% | -6.2% |
| Q2 2013 | $43,840,000 | – | 3,795,654 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |